SCHEMBL698934

SCHEMBL698934

Cc1ccc(CCOC(=O)n2ccnc2[C@@H](C)c2cccc(C)c2C)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 3/20 0.33
CHRM4 P08173 3/20 0.33
CHRM5 P08912 3/20 0.33
CHRM1 P11229 3/20 0.33
CHRM3 P20309 3/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
LMNA P02545 2/20 0.32
GRIN2B Q13224 2/20 0.32
ADORA3 P0DMS8 1/20 0.32
HTR2A P28223 1/20 0.32
HTR7 P34969 1/20 0.32
OPRM1 P35372 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
SLC2A1 P11166 1/20 0.31
POLB P06746 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3529304 0.93 GRIN2B (0.37) PPARGPPARDPPARALMNAGRIN2B
SCHEMBL697839 0.92 FPR2 (0.35) CHRM5CHRM1PPARGPPARDPPARA
SCHEMBL723424 0.90 NPC1 (0.33) PPARGPPARDPPARALMNAGRIN2B
SCHEMBL723425 0.90 NPC1 (0.33) PPARGPPARDPPARALMNAGRIN2B
SCHEMBL3532613 0.90 ALOX5 (0.36) CHRM5CHRM1LMNAGRIN2BPOLB
SCHEMBL698126 0.90 GRIN2B (0.41) LMNAGRIN2BRAB9ASMN1; SMN2
SCHEMBL3531096 0.88 CES2 (0.38) PPARGPPARDPPARA
SCHEMBL703068 0.87 ALDH1A1 (0.33) LMNAHTR7POLBSMN1; SMN2MAPK1
SCHEMBL698909 0.87 KDM4E (0.33) LMNAGRIN2BPOLBSMN1; SMN2
SCHEMBL698721 0.87 LMNA (0.38) PPARGPPARDPPARALMNAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CHRM2 831/4885CHRM4 1035/4885CHRM5 1415/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CHRM2 831/4885CHRM4 1035/4885CHRM5 1415/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CHRM2 831/4885CHRM4 1035/4885CHRM5 1415/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 CHRM2 831/4885CHRM4 1035/4885CHRM5 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.